Education
About Us
Working with TipRanks
Follow Us
Hangzhou Tigermed Consulting Co., Ltd. Class H (DE:5HZ1)
FRANKFURT:5HZ1
Total Valuation
Hangzhou Tigermed Consulting Co., Ltd. Class H has a market cap or net worth of €5.79B. The enterprise value is €45.03B.
Market Cap€5.79B
Enterprise Value€45.03B
Share Statistics
Hangzhou Tigermed Consulting Co., Ltd. Class H has 123,124,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding123,124,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hangzhou Tigermed Consulting Co., Ltd. Class H’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.66%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.66%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee648.32K
Profits Per Employee43.97K
Employee Count10,185
Asset Turnover0.23
Inventory Turnover136.47
Valuation Ratios
The current PE Ratio of Hangzhou Tigermed Consulting Co., Ltd. Class H is 64.1. Hangzhou Tigermed Consulting Co., Ltd. Class H’s PEG ratio is -0.77.
PE Ratio64.1
PS Ratio3.79
PB Ratio1.21
Price to Fair Value1.21
Price to FCF33.79
Price to Operating Cash Flow37.44
PEG Ratio-0.77
Income Statement
In the last 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H had revenue of 6.60B and earned 405.14M in profits. Earnings per share was 0.47.
Revenue6.60B
Gross Profit2.24B
Operating Income664.42M
Pretax Income664.46M
Net Income405.14M
EBITDA1.13B
Earnings Per Share (EPS)0.47
Cash Flow
In the last 12 months, operating cash flow was 889.20M and capital expenditures -253.32M, giving a free cash flow of 1.15B billion.
Operating Cash Flow889.20M
Free Cash Flow1.15B
Free Cash Flow per Share9.37
Dividends & Yields
Hangzhou Tigermed Consulting Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.67
52-Week Price Change26.03%
50-Day Moving Average5.13
200-Day Moving Average4.82
Relative Strength Index (RSI)44.24
Average Volume (3m)6.00
Important Dates
Hangzhou Tigermed Consulting Co., Ltd. Class H upcoming earnings date is Mar 31, 2026, TBA (Not Confirmed).
Last Earnings DateOct 28, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend Date―
Financial Position
Hangzhou Tigermed Consulting Co., Ltd. Class H as a current ratio of 1.72, with Debt / Equity ratio of 8.27%
Current Ratio1.72
Quick Ratio1.71
Debt to Market Cap0.09
Net Debt to EBITDA0.51
Interest Coverage Ratio4.70
Taxes
In the past 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H has paid 216.63M in taxes.
Income Tax216.63M
Effective Tax Rate0.33
Enterprise Valuation
Hangzhou Tigermed Consulting Co., Ltd. Class H EV to EBITDA ratio is 22.66, with an EV/FCF ratio of 34.57.
EV to Sales3.88
EV to EBITDA22.66
EV to Free Cash Flow34.57
EV to Operating Cash Flow23.34
Balance Sheet
Hangzhou Tigermed Consulting Co., Ltd. Class H has €1.71B in cash and marketable securities with €1.75B in debt, giving a net cash position of -€46.00M billion.
Cash & Marketable Securities€1.71B
Total Debt€1.75B
Net Cash-€46.00M
Net Cash Per Share-€0.37
Tangible Book Value Per Share€23.70
Margins
Gross margin is 26.51%, with operating margin of 10.06%, and net profit margin of 6.14%.
Gross Margin26.51%
Operating Margin10.06%
Pretax Margin10.06%
Net Profit Margin6.14%
EBITDA Margin17.11%
EBIT Margin12.20%
Analyst Forecast
The average price target for Hangzhou Tigermed Consulting Co., Ltd. Class H is €6.83, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€6.83
Price Target Upside19.84% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―